Doing meticulous work is the top priority of the pharmaceutical investment enterprise

Industry medicine investment experts believe that when a pharmaceutical investment enterprise adopts the pharmaceutical investment model to sell drugs, it is of utmost importance to make the investment promotion work fine. There are many details of the pharmaceutical investment promotion that require us to pay attention. Among them, the mentality of pharmaceutical investment personnel should be calm. Peace of mind is particularly critical for health products or fast-moving consumer goods pharmaceutical investment companies. Recruiting distributors that meet the company's development requirements, quickly focusing funds, displaying corporate strength, training marketing teams, and expanding business impact are the main objectives, but Can not meet the demand, can not go outside the door to ramp up for investment promotion, mongolian money is another abnormal state of mind.

Pharmaceutical agents believe that respecting distributors is an essential quality for pharmaceutical investment workers. "If you want to respect yourself, you must first respect others," respect the dealers, you may be respected by the dealers; but only to win respect from the dealers, care can naturally follow, the cooperation between manufacturers can be further in-depth expand. In marketing work, respecting distributors, strengthening the feelings between the two parties, and attracting dealers through personal communication are a kind of cost-effective means. A colleague I know has been very successful in using emotion to win over dealers. He once attended the wedding as the best man of the local largest dealership. The best man in the trade only had him as an “outsider”; he changed several pharmaceutical investment enterprises, and the local mainstream dealer followed his turn to change his main product.

Experts from the Pharmaceutical Investment Network said that the product is the root of all marketing strategies and is the starting point for sales. To increase sales, we must first find products that are suitable for the region. One more thing we want to classify is the basic product, which is the largest product sold in the region. This is the main source of our sales. The second is the core product. This is the future competitive advantage of the region. Now the product is in growth. However, in the future, it must be the focus of competition. Third, it is to block products. This is our product aimed at competitors and is mainly used to crack down on rivals' core products and basic products.

The medical agent believes that the form of investment promotion can be arbitrary, but the division of labor and functions must be clear. The most important thing is that the customer selection criteria should be unified and the operation area should be clearly defined so as to avoid crashes and fires. There are also some pharmaceutical investment promotion companies that have become “professional investment merchants,” and they constantly develop products, constantly submitting document numbers, advertising advertisements for pharmaceuticals, and making pharmaceutical investment the main source of profits. Despite a dead one, he still did not stop and hit a shot for a place. As a result, the market was disrupted and the product was dead. The pharmaceutical agency network pointed out that product differentiation is yet another barrier in front of the company.

In addition, pharmaceutical agents believe that in this homogenized investment promotion industry, companies should seek to establish a foothold in their products, take the road to a differentiated product brand, find selling points, and expand their sales to attract customers and reach orders. As a result, the company’s performance has improved and the company has been successful. In pharmaceutical investment promotion, pharmaceutical investment enterprises should pay attention to the details of the company, and the so-called details determine success or failure.

The pharmaceutical agent pointed out that if medicine investment is weaker than competitors, what we need to do is not hard and hard. What we need to do is misplaced marketing, misplaced channels, dislocation of products, and dislocation of terminals. We find opportunities in dislocations. This is a great disparity in strength. Situation. If we are weaker, but the strength is not much different, the strategy we adopt is to follow the strategy of adding innovations. We must conduct category innovation, channel innovation, and terminal strategy innovation in the follow-up. We must also be adept at catching up with the disadvantages of our opponents. . In addition, in the view of pharmaceutical investment promotion, in view of the important role of current pharmaceutical exhibitions, pharmaceutical investment promotion companies can also use their market or channel development needs to take advantage of the opportunity of the China Merchants Medicine Fair to conduct local product promotion, business negotiation, and Forum communication, cocktail seminars, lecturer training, etc., can also be targeted to the development of a region or a channel of customers.